Early Day Motion·EDM 1012

Implementation of the Independent Medicines and Medical Devices Safety Review recommendations

28 February 202219 Signatures

Primary sponsor

Cat Smith

LabourLancaster and Wyre

Motion Text

That this House notes that sodium valproate can cause serious problems in a developing baby; further notes that 10 per cent of babies whose mothers take sodium valproate during pregnancy are at risk of having a birth defect, and up to 40 per cent have problems with development and learning as they grow; welcomes the July 2020 Independent Medicines and Medical Devices Safety Review; and calls on the Government to implement its recommendations in full, including paying compensation to people disabled by sodium valproate.